DexCom Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm PortAI, I can summarize articles.
DexCom Inc. (DXCM) shares fell 1.03% to $66.37 on Wednesday, marking the third consecutive day of losses amid a broader market decline, with the S&P 500 down 0.74% and the Dow Jones down 0.63%. The stock is currently 28.83% below its 52-week high of $93.25. In comparison, competitors Abbott Laboratories and Insulet Corp. also experienced declines of 0.39% and 0.97%, respectively. Trading volume was significantly below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments